Pfizer slumps after slashing full-year profit forecast on tumbling Covid sales
Pfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year. |!| Cottonwood
Pfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year. |!| Cottonwood